350 Epizód

  1. 228: A surprise success in Alzheimer's and how FDA history seeded modern controversy

    Közzétéve: 2022. 09. 29.

  2. 227: Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0

    Közzétéve: 2022. 09. 22.

  3. 226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred

    Közzétéve: 2022. 09. 15.

  4. 225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding

    Közzétéve: 2022. 09. 08.

  5. 224: The anti-aging research boom, the Godfather of biotech, & the future of Biogen

    Közzétéve: 2022. 09. 01.

  6. 223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO

    Közzétéve: 2022. 08. 25.

  7. 222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment

    Közzétéve: 2022. 08. 18.

  8. 221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing

    Közzétéve: 2022. 08. 11.

  9. 220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble

    Közzétéve: 2022. 08. 04.

  10. 219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data

    Közzétéve: 2022. 07. 28.

  11. 218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search

    Közzétéve: 2022. 07. 21.

  12. 217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'

    Közzétéve: 2022. 07. 14.

  13. 216: VC malaise, FDA confusion, & yet another Alzheimer's debate

    Közzétéve: 2022. 07. 07.

  14. 215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines

    Közzétéve: 2022. 06. 30.

  15. 214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict

    Közzétéve: 2022. 06. 23.

  16. 213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback

    Közzétéve: 2022. 06. 16.

  17. 212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

    Közzétéve: 2022. 06. 09.

  18. 211: Biotech's catch-22, a $100 genome, & dealing with monkeypox

    Közzétéve: 2022. 06. 02.

  19. 210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

    Közzétéve: 2022. 05. 26.

  20. Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison

    Közzétéve: 2022. 05. 19.

7 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site